Cite
Human Mesenchymal Stem Cells as a Carrier for a Cell-Mediated Drug Delivery.
MLA
Litvinova, L. S., et al. “Human Mesenchymal Stem Cells as a Carrier for a Cell-Mediated Drug Delivery.” Frontiers in Bioengineering and Biotechnology, vol. 10, Feb. 2022, p. 796111. EBSCOhost, https://doi.org/10.3389/fbioe.2022.796111.
APA
Litvinova, L. S., Shupletsova, V. V., Khaziakhmatova, O. G., Daminova, A. G., Kudryavtseva, V. L., Yurova, K. A., Malashchenko, V. V., Todosenko, N. M., Popova, V., Litvinov, R. I., Korotkova, E. I., Sukhorukov, G. B., Gow, A. J., Weissman, D., Atochina-Vasserman, E. N., & Khlusov, I. A. (2022). Human Mesenchymal Stem Cells as a Carrier for a Cell-Mediated Drug Delivery. Frontiers in Bioengineering and Biotechnology, 10, 796111. https://doi.org/10.3389/fbioe.2022.796111
Chicago
Litvinova, L S, V V Shupletsova, O G Khaziakhmatova, A G Daminova, V L Kudryavtseva, K A Yurova, V V Malashchenko, et al. 2022. “Human Mesenchymal Stem Cells as a Carrier for a Cell-Mediated Drug Delivery.” Frontiers in Bioengineering and Biotechnology 10 (February): 796111. doi:10.3389/fbioe.2022.796111.